Book contents
- The Cambridge Handbook of Personality Disorders
- The Cambridge Handbook of Personality Disorders
- Copyright page
- Contents
- Figures
- Tables
- Contributors
- Preface
- Part I Etiology
- Part II Models
- Part III Individual Disorders and Clusters
- Part IV Assessment
- Part V Treatment
- 17 Cognitive Behavioral Approaches
- 17a Applying a Cognitive-Behavioral, Principle-Based Approach to the Treatment of Personality Disorders: Commentary on Cognitive Behavioral Approaches
- 17b Implementation Challenges in Real World Settings: Commentary on Cognitive Behavioral Approaches
- 17c Further Considerations about Cognitive Behavioral Therapies and Personality Disorders: Author Rejoinder to Commentaries on Cognitive Behavioral Approaches
- 18 Psychoanalytic/Psychodynamic Approaches to Personality Disorders
- 18a Contemporary Psychodynamic Treatments: Commentary on Psychoanalytic/Psychodynamic Approaches to Personality Disorders
- 18b Consideration of Commonalities in Distinct Models of Treatment for Individuals with Borderline Personality Disorder: Commentary on Psychoanalytic/Psychodynamic Approaches to Personality Disorders
- 18c Further Development of Three Key Issues: Author Rejoinder to Commentaries on Psychoanalytic/Psychodynamic Approaches to Personality Disorders
- 19 Using DSM-5 and ICD-11 Personality Traits in Clinical Treatment
- 19a A Functional Understanding of the Relationship between Personality and Clinical Diagnoses and Implications for Treatment Planning: Commentary on Using DSM-5 and ICD-11 Personality Traits in Clinical Treatment
- 19b The Need for Mechanistic Models to Translate Traits from Bench to Bedside: Commentary on Using DSM-5 and ICD-11 Personality Traits in Clinical Treatment
- 19c Simplicity and Dynamics of the ICD-11 Trait Qualifiers in Relation to Treatment: Author Rejoinder to Commentaries on Using DSM-5 and ICD-11 Personality Traits in Clinical Treatment
- 20 Brief Therapeutic Approaches for Personality Disorders
- 20a What Knowledge Is Lacking on Brief Interventions for Personality Disorders and Why: Commentary on Brief Therapeutic Approaches for Personality Disorders
- 20b Short- and Long-Term Personality Disorder Treatment Studies Should Inform One Another: Commentary on Brief Therapeutic Approaches for Personality Disorders
- 20c Next Steps: Author Rejoinder to Commentaries on Brief Therapeutic Approaches for Personality Disorders
- 21 Recent Developments in the Pharmacologic Management of Personality Disorders
- 21a New Efforts towards Evidence-Informed Practice and Practice-Informed Research: Commentary on Recent Developments in the Pharmacologic Management of Personality Disorders
- 21b Considerations Regarding the Pharmacological Management of Personality Disorders: Commentary on Recent Developments in the Pharmacologic Management of Personality Disorders
- 21c Directions for Future Drug Trial Research: Author Rejoinder to Commentaries on Recent Developments in the Pharmacologic Management of Personality Disorders
- Index
- References
21b - Considerations Regarding the Pharmacological Management of Personality Disorders: Commentary on Recent Developments in the Pharmacologic Management of Personality Disorders
from Part V - Treatment
Published online by Cambridge University Press: 24 February 2020
- The Cambridge Handbook of Personality Disorders
- The Cambridge Handbook of Personality Disorders
- Copyright page
- Contents
- Figures
- Tables
- Contributors
- Preface
- Part I Etiology
- Part II Models
- Part III Individual Disorders and Clusters
- Part IV Assessment
- Part V Treatment
- 17 Cognitive Behavioral Approaches
- 17a Applying a Cognitive-Behavioral, Principle-Based Approach to the Treatment of Personality Disorders: Commentary on Cognitive Behavioral Approaches
- 17b Implementation Challenges in Real World Settings: Commentary on Cognitive Behavioral Approaches
- 17c Further Considerations about Cognitive Behavioral Therapies and Personality Disorders: Author Rejoinder to Commentaries on Cognitive Behavioral Approaches
- 18 Psychoanalytic/Psychodynamic Approaches to Personality Disorders
- 18a Contemporary Psychodynamic Treatments: Commentary on Psychoanalytic/Psychodynamic Approaches to Personality Disorders
- 18b Consideration of Commonalities in Distinct Models of Treatment for Individuals with Borderline Personality Disorder: Commentary on Psychoanalytic/Psychodynamic Approaches to Personality Disorders
- 18c Further Development of Three Key Issues: Author Rejoinder to Commentaries on Psychoanalytic/Psychodynamic Approaches to Personality Disorders
- 19 Using DSM-5 and ICD-11 Personality Traits in Clinical Treatment
- 19a A Functional Understanding of the Relationship between Personality and Clinical Diagnoses and Implications for Treatment Planning: Commentary on Using DSM-5 and ICD-11 Personality Traits in Clinical Treatment
- 19b The Need for Mechanistic Models to Translate Traits from Bench to Bedside: Commentary on Using DSM-5 and ICD-11 Personality Traits in Clinical Treatment
- 19c Simplicity and Dynamics of the ICD-11 Trait Qualifiers in Relation to Treatment: Author Rejoinder to Commentaries on Using DSM-5 and ICD-11 Personality Traits in Clinical Treatment
- 20 Brief Therapeutic Approaches for Personality Disorders
- 20a What Knowledge Is Lacking on Brief Interventions for Personality Disorders and Why: Commentary on Brief Therapeutic Approaches for Personality Disorders
- 20b Short- and Long-Term Personality Disorder Treatment Studies Should Inform One Another: Commentary on Brief Therapeutic Approaches for Personality Disorders
- 20c Next Steps: Author Rejoinder to Commentaries on Brief Therapeutic Approaches for Personality Disorders
- 21 Recent Developments in the Pharmacologic Management of Personality Disorders
- 21a New Efforts towards Evidence-Informed Practice and Practice-Informed Research: Commentary on Recent Developments in the Pharmacologic Management of Personality Disorders
- 21b Considerations Regarding the Pharmacological Management of Personality Disorders: Commentary on Recent Developments in the Pharmacologic Management of Personality Disorders
- 21c Directions for Future Drug Trial Research: Author Rejoinder to Commentaries on Recent Developments in the Pharmacologic Management of Personality Disorders
- Index
- References
Summary
Despite the advancements in the development of pharmacological interventions for personality disorders (PDs), clinicians should be relatively cautious about the potential benefits of using pharmacological agents for the treatment of PDs when facing therapeutic decisions for individual patients. The pharmacological management of PDs is considerably complex; frequent treatment drop-out, non-compliance, and adverse effects illustrate why having a good therapeutic relationship with patients is a particularly important factor for the success of pharmacological treatment of PDs. Results from clinical trials for PDs may not be generalizable for individual patients in the community. PDs are heterogeneous conditions associated with many psychiatric disorders. Yet, clinical trials frequently include highly selected populations that do not necessarily correspond to typical patients with PDs found in community settings. Considering that PDsfrequently co-occur with other psychiatric diagnoses, a promising approach to future research in PDs should consider the development of treatment algorithms based on co-occurring disorders. This approach is likely to resonate with prescribing physicians trained to evaluate patients systematically for the presence or absence of specific disorders. For instance, this approach has been increasingly studied in gambling disorder, with promising findings reported thus far.
Keywords
- Type
- Chapter
- Information
- The Cambridge Handbook of Personality Disorders , pp. 517 - 520Publisher: Cambridge University PressPrint publication year: 2020